Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00094861 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Dysphagia
Non-Small Cell Lung Cancer
Lung Cancer

Interventions

DRUG: Palifermin
DRUG: Placebo
RADIATION: Radiotherapy
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]